Advertisement
ORAL PRESENTATIONS: Thursday 23 June: Hepatitis C: Clinical aspects and therapy| Volume 77, SUPPLEMENT 1, S16, July 01, 2022

Effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients previously treated with direct-acting antiviral agents (DAA)

      This paper is only available as a PDF. To read, Please Download here.